Titre : Esclaves

Esclaves : Questions médicales fréquentes

Termes MeSH sélectionnés :

Selective Estrogen Receptor Modulators
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Esclaves : Questions médicales les plus fréquentes", "headline": "Esclaves : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Esclaves : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-26", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Esclaves" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Esclaves", "alternateName": "Enslaved Persons", "code": { "@type": "MedicalCode", "code": "D063948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mark L Latash", "url": "https://questionsmedicales.fr/author/Mark%20L%20Latash", "affiliation": { "@type": "Organization", "name": "Department of Kinesiology, The Pennsylvania State University, Rec.Hall-267, University Park, PA, 16802, USA. mll11@psu.edu." } }, { "@type": "Person", "name": "Eugene T Richardson", "url": "https://questionsmedicales.fr/author/Eugene%20T%20Richardson", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Momin M Malik", "url": "https://questionsmedicales.fr/author/Momin%20M%20Malik", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "William A Darity", "url": "https://questionsmedicales.fr/author/William%20A%20Darity", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "A Kirsten Mullen", "url": "https://questionsmedicales.fr/author/A%20Kirsten%20Mullen", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35611405", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jmedchem.2c00525" } }, { "@type": "ScholarlyArticle", "name": "Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges.", "datePublished": "2023-06-28", "url": "https://questionsmedicales.fr/article/37377342", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jmedchem.3c00136" } }, { "@type": "ScholarlyArticle", "name": "New steps on an old path: Novel estrogen receptor inhibitors in breast cancer.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36374739", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.critrevonc.2022.103861" } }, { "@type": "ScholarlyArticle", "name": "Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2).", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/36977973", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12282-023-01443-8" } }, { "@type": "ScholarlyArticle", "name": "Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SERMs).", "datePublished": "2022-08-19", "url": "https://questionsmedicales.fr/article/36017417", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/CCID.S333663" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Esclaves", "item": "https://questionsmedicales.fr/mesh/D063948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Esclaves - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Esclaves", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Esclaves", "description": "Comment identifier une personne esclave ?\nQuels tests peuvent aider au diagnostic ?\nQuels signes physiques peuvent indiquer l'esclavage ?\nComment évaluer le traumatisme psychologique ?\nQuels professionnels peuvent diagnostiquer l'esclavage ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Selective+Estrogen+Receptor+Modulators&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Esclaves", "description": "Quels symptômes psychologiques sont fréquents ?\nQuels symptômes physiques peuvent apparaître ?\nComment l'esclavage affecte-t-il la santé mentale ?\nY a-t-il des symptômes de stress post-traumatique ?\nQuels comportements peuvent être observés ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Selective+Estrogen+Receptor+Modulators&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Esclaves", "description": "Comment prévenir l'esclavage moderne ?\nQuel rôle jouent les gouvernements ?\nComment les ONG contribuent-elles à la prévention ?\nPourquoi l'éducation est-elle cruciale ?\nComment les entreprises peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Selective+Estrogen+Receptor+Modulators&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Esclaves", "description": "Quels traitements psychologiques sont recommandés ?\nComment traiter les blessures physiques ?\nY a-t-il des médicaments pour les symptômes ?\nQuel rôle joue le soutien communautaire ?\nComment les groupes de soutien peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Selective+Estrogen+Receptor+Modulators&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Esclaves", "description": "Quelles sont les complications psychologiques ?\nY a-t-il des complications physiques ?\nComment l'esclavage affecte-t-il les relations sociales ?\nQuelles sont les conséquences économiques ?\nComment l'esclavage impacte-t-il la famille ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Selective+Estrogen+Receptor+Modulators&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Esclaves", "description": "Quels sont les facteurs de risque socio-économiques ?\nComment la migration influence-t-elle le risque ?\nQuels groupes sont plus à risque ?\nQuel rôle joue la culture dans le risque d'esclavage ?\nComment les conflits armés affectent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Selective+Estrogen+Receptor+Modulators&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une personne esclave ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification repose sur des signes de contrainte, isolement et absence de liberté." } }, { "@type": "Question", "name": "Quels tests peuvent aider au diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des entretiens, évaluations psychologiques et observations des conditions de vie sont utiles." } }, { "@type": "Question", "name": "Quels signes physiques peuvent indiquer l'esclavage ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des blessures, malnutrition et signes de négligence sont souvent observés." } }, { "@type": "Question", "name": "Comment évaluer le traumatisme psychologique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des outils d'évaluation standardisés peuvent mesurer l'impact psychologique de l'esclavage." } }, { "@type": "Question", "name": "Quels professionnels peuvent diagnostiquer l'esclavage ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs sociaux, psychologues et médecins sont souvent impliqués dans le diagnostic." } }, { "@type": "Question", "name": "Quels symptômes psychologiques sont fréquents ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Anxiété, dépression et stress post-traumatique sont courants chez les esclaves." } }, { "@type": "Question", "name": "Quels symptômes physiques peuvent apparaître ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue chronique, douleurs corporelles et troubles alimentaires sont souvent signalés." } }, { "@type": "Question", "name": "Comment l'esclavage affecte-t-il la santé mentale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'esclavage peut entraîner des troubles mentaux graves, y compris des troubles de l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes de stress post-traumatique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, flashbacks, cauchemars et évitement de situations rappelant l'esclavage sont fréquents." } }, { "@type": "Question", "name": "Quels comportements peuvent être observés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Isolement social, méfiance et comportements autodestructeurs peuvent être présents." } }, { "@type": "Question", "name": "Comment prévenir l'esclavage moderne ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation, la sensibilisation et des lois strictes sont essentielles pour prévenir l'esclavage." } }, { "@type": "Question", "name": "Quel rôle jouent les gouvernements ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les gouvernements doivent adopter des lois et politiques pour protéger les droits humains." } }, { "@type": "Question", "name": "Comment les ONG contribuent-elles à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les ONG sensibilisent, soutiennent les victimes et plaident pour des changements législatifs." } }, { "@type": "Question", "name": "Pourquoi l'éducation est-elle cruciale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide à sensibiliser les populations aux dangers de l'esclavage et à ses signes." } }, { "@type": "Question", "name": "Comment les entreprises peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les entreprises doivent adopter des pratiques éthiques et surveiller leurs chaînes d'approvisionnement." } }, { "@type": "Question", "name": "Quels traitements psychologiques sont recommandés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie cognitivo-comportementale et le soutien psychologique sont efficaces." } }, { "@type": "Question", "name": "Comment traiter les blessures physiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les soins médicaux appropriés, y compris la réhabilitation physique, sont essentiels." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antidépresseurs et anxiolytiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Quel rôle joue le soutien communautaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le soutien communautaire aide à la réintégration et à la guérison des victimes." } }, { "@type": "Question", "name": "Comment les groupes de soutien peuvent-ils aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les groupes de soutien offrent un espace sécurisé pour partager des expériences et guérir." } }, { "@type": "Question", "name": "Quelles sont les complications psychologiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent souffrir de troubles mentaux persistants, comme la dépression chronique." } }, { "@type": "Question", "name": "Y a-t-il des complications physiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies chroniques, blessures non traitées et problèmes de santé peuvent survenir." } }, { "@type": "Question", "name": "Comment l'esclavage affecte-t-il les relations sociales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent éprouver des difficultés à établir des relations saines après l'esclavage." } }, { "@type": "Question", "name": "Quelles sont les conséquences économiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent avoir des difficultés à trouver un emploi et à subvenir à leurs besoins." } }, { "@type": "Question", "name": "Comment l'esclavage impacte-t-il la famille ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les familles peuvent être déchirées, et les enfants peuvent souffrir de traumatismes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque socio-économiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "La pauvreté, le manque d'éducation et l'instabilité politique augmentent le risque d'esclavage." } }, { "@type": "Question", "name": "Comment la migration influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les migrants sont souvent vulnérables à l'exploitation et à l'esclavage en raison de leur statut." } }, { "@type": "Question", "name": "Quels groupes sont plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes, les enfants et les minorités ethniques sont souvent plus exposés à l'esclavage." } }, { "@type": "Question", "name": "Quel rôle joue la culture dans le risque d'esclavage ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines cultures peuvent normaliser l'exploitation, augmentant ainsi le risque d'esclavage." } }, { "@type": "Question", "name": "Comment les conflits armés affectent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les conflits créent des conditions propices à l'esclavage, en augmentant la vulnérabilité des populations." } } ] } ] }

Sources (10000 au total)

Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer.

Breast cancer (BC) is a multifactorial disease and is prone to drug resistance during treatment. In this study, we described a new class of multifunctional estrogen receptor (ER) modulators ground on ...

Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2).

This AMEERA-2 study evaluated the pharmacokinetics, efficacy, and safety of the oral selective estrogen receptor degrader amcenestrant as a monotherapy with dose escalation in Japanese postmenopausal ... In this open-label, nonrandomized, phase I study, patients received amcenestrant 400 mg once daily (QD) (n = 7) and 300 mg twice daily (BID) (n = 3). The incidence of dose-limiting toxicities (DLT), r... No DLTs were observed and MTD was not reached in the 400 mg QD group. One DLT (grade 3 maculopapular rash) was reported in a patient treated with 300 mg BID. After repeated oral administration of eith... Amcenestrant 400 mg QD has a favorable safety profile and has been selected as the recommended Phase II dose for monotherapy for evaluating the safety and efficacy of amcenestrant in a larger, global,... Clinical trial registration NCT03816839....

Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators.

Osteoporosis is a debilitating silent disease with a huge socio-economic impact. Prevention strategies and early detection of osteoporosis need to be carried out in every health care unit to substanti... This article reviews the evidences available on searches from PubMed and The National Library of Medicine, author's opinions based on clinical experience. There is a need for escalating the efforts to... Early menopause is within 10 years of menopause and late menopause is considered beyond 10 years of menopause. HT is a cost-effective therapy in the early post menopause especially in symptomatic wome...

The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia.

The impact of osteopenia as a risk factor for fractures is underrecognized. Moreover, the efficacy of selective estrogen receptor modulators (SERMs) in postmenopausal women with osteopenia is limited.... Thirty-two postmenopausal women with osteopenia were treated with 3 types of SERMs medication: raloxifene (group I, N=15), bazedoxifene (group II, N=8), and raloxifene with cholecalciferol (group III,... Patients in group I showed significant increases in hip BMD, -1.93 to -1.73 and spine BMD, -1.85 to -1.67. In addition, patients in groups II and III showed significant increases in hip BMD, -1.93 to ... In this study, we found that SERMs could improve spine and hip BMD. In conclusion, preemptive treatment using SERMs is necessary for postmenopausal women with osteopenia. None of the patients experien...